Exponent Inc. (EXPO) Sees Large Volume Increase
Shares of Exponent Inc. (NASDAQ:EXPO) saw an uptick in trading volume on Friday . 184,189 shares changed hands during trading, an increase of 83% from the previous session’s volume of 100,715 shares.The stock last traded at $58.22 and had previously closed at $57.69.
A number of brokerages have commented on EXPO. Avondale Partners began coverage on shares of Exponent in a research note on Thursday. They set a “market perform” rating and a $60.00 price target for the company. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $57.00 price target for the company in a research note on Friday, April 22nd.
The firm has a market capitalization of $1.51 billion and a price-to-earnings ratio of 32.71. The company’s 50 day moving average price is $55.20 and its 200 day moving average price is $50.50.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Wednesday, April 20th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.05. The firm had revenue of $79 million for the quarter, compared to analysts’ expectations of $77.15 million. During the same period last year, the company earned $0.75 earnings per share. The firm’s revenue was up 3.8% on a year-over-year basis. Equities research analysts forecast that Exponent Inc. will post $1.84 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 24th. Stockholders of record on Friday, June 10th were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Wednesday, June 8th. This represents a $0.72 annualized dividend and a dividend yield of 1.24%.
In other news, VP Catherine Corrigan sold 6,723 shares of the company’s stock in a transaction that occurred on Wednesday, May 18th. The stock was sold at an average price of $50.32, for a total transaction of $338,301.36. Following the sale, the vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $1,717,119.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Robert D. Caligiuri sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, May 9th. The stock was sold at an average price of $50.00, for a total value of $125,000.00. Following the sale, the vice president now directly owns 130,812 shares in the company, valued at $6,540,600. The disclosure for this sale can be found here.
Several hedge funds have recently modified their holdings of the company. WBI Investments Inc. purchased a new stake in shares of Exponent during the fourth quarter valued at about $1,957,000. Wells Fargo & Company MN increased its position in Exponent by 14.8% in the fourth quarter. Wells Fargo & Company MN now owns 326,619 shares of the company’s stock valued at $16,314,000 after buying an additional 42,025 shares in the last quarter. Comerica Bank increased its position in Exponent by 0.7% in the fourth quarter. Comerica Bank now owns 27,900 shares of the company’s stock valued at $1,322,000 after buying an additional 203 shares in the last quarter. California Public Employees Retirement System increased its position in Exponent by 11.6% in the fourth quarter. California Public Employees Retirement System now owns 106,400 shares of the company’s stock valued at $5,315,000 after buying an additional 11,100 shares in the last quarter. Finally, Henderson Group PLC increased its position in Exponent by 1.6% in the fourth quarter. Henderson Group PLC now owns 181,163 shares of the company’s stock valued at $9,049,000 after buying an additional 2,871 shares in the last quarter.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.